Multidimensional analysis of immune response identified biomarkers of recent Mycobacterium tuberculosis infection

Tessa Lloyd; Pia Steigler; Cheleka A.M. Mpande; Virginie Rozot; Boitumelo Mosito; Constance Shreuder; Timothy D. Reid; Mark Hatherill; Thomas J. Scriba; Francesca Little; Elisa Nemes; the ACS Study Team

doi:10.1101/2021.01.27.21250605

Article Information

doi

https://doi.org/10.1101/2021.01.27.21250605

History

January 29, 2021.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

Tessa Lloyd1,2,
Pia Steigler1,3,
Cheleka A.M. Mpande1,
Virginie Rozot1,
Boitumelo Mosito1,
Constance Shreuder1,
Timothy D. Reid1,
Mark Hatherill1,
Thomas J. Scriba1,
Francesca Little2,*,
Elisa Nemes1,*,#,
the ACS Study Team1

¹South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
²Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa
³Wellcome Centre for Infectious Diseases Research (CIDRI) in Africa, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Medicine, University of Cape Town, South Africa